buPROPion Hydrochloride Extended-release Tablets USP — Class II drug recall D-0590-2024
Ongoing recall by Amerisource Health Services LLC, reported 2024-07-17, distributed nationwide. Failed Dissolution Specifications; the product is dissolving faster than the specified limits.
| Recall number | D-0590-2024 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Amerisource Health Services LLC, Columbus, OH, United States |
| Recall initiated | 2024-06-24 |
| Classified | 2024-07-08 |
| Reported by FDA | 2024-07-17 |
| Distributed | Nationwide (US) |
| Quantity | 2,484 cartons |
| Reason classes | specification failure |
| NDC | 60687-0782, 60687-0782-01, 60687-0782-11, 60687-0793, 60687-0793-11, 60687-0793-21 |
| Lot numbers | 1017343 |
| Expiration dates | 2025-12-31 |
Product
buPROPion Hydrochloride Extended-release Tablets USP (XL) Once-Daily, 150 mg, 100 Tablets (10 x 10) per carton, Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217, NDC: 60687-782-01.
Reason for recall
Failed Dissolution Specifications; the product is dissolving faster than the specified limits.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0590-2024. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.